Acquisition of US-based Fortress Medical Systems accelerates BID Equity‘s life science software group around German XClinical and French Carenity
BID Equity Fund II, a fund advised by BID Equity, acquires Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system.
The recent transaction which followed shortly on the acquisition of the French analytics platform Carenity, enables BID Equity’s life science platform around German XClinical and French Carenity to expand its footprint in the US market and gain new customer segments in the medical device manufacturer and pharmaceutical segments.
Fortress Medical Systems was founded in 1997. Their flagship product Clindex® is known as one of the first integrated software systems designed for clinical trials.